A Clinical Trial to Evaluate Efficacy of Once or Twice ZOledronic Acid After Different Duration of denOsumMab Administration in Postmenopausal Women With Osteoporosis (ZOOM Study)

NCT05361408 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

114

Enrollment

OTHER

Sponsor class

Conditions

Osteoporosis

Interventions

DRUG: Zoledronic acid, once
DRUG: Zoledronic acid, twice

Sponsor

Yonsei University